首页 > 最新文献

Journal of Hospital Infection最新文献

英文 中文
The role of colonization with resistant Gram-negative bacteria in the treatment of febrile neutropenia after stem cell transplantation 耐药革兰氏阴性菌定植在治疗干细胞移植后发热性中性粒细胞减少症中的作用。
IF 3.9 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-11-01 DOI: 10.1016/j.jhin.2024.08.012
T. Sokolová , P. Paterová , A. Zavřelová , B. Víšek , P. Žák , J. Radocha

Background

Febrile neutropenia (FN) is a common complication of stem cell transplantation.

Aim

To evaluate the frequency of sepsis in patients with FN colonized with resistant Gram-negative bacteria (extended-spectrum β-lactamase (ESBL)-positive, multidrug-resistant (MDR) Pseudomonas aeruginosa) and the choice of primary antibiotic in colonized patients.

Methods

This retrospective study analysed data from patients undergoing haematopoietic stem cell transplantation from January 2018 to September 2022. Data were extracted from the hospital information system.

Findings

Carbapenem as the primary antibiotic of choice was chosen in 10.9% of non-colonized +/–AmpC patients, 31.5% of ESBL+ patients, and 0% of MDR P. aeruginosa patients. Patients with FN and MDR P. aeruginosa colonization had a high prevalence of sepsis (namely 100%, P = 0.0197). The spectrum of sepsis appeared to be different, with Gram-negative bacilli predominating in the ESBL+ group (OR: 5.39; 95% CI: 1.55–18.76; P = 0.0123). Colonizer sepsis was present in 100% of sepsis with MDR P. aeruginosa colonization (P = 0.002), all in allogeneic transplantation (P = 0.0003), with a mortality rate of 33.3% (P = 0.0384). The incidence of sepsis in patients with ESBL+ colonization was 25.9% (P = 0.0197), with colonizer sepsis in 50% of sepsis cases (P = 0.0002), most in allogeneic transplantation (P = 0.0003).

Conclusion

The results show a significant risk of sepsis in FN with MDR P. aeruginosa colonization, a condition almost exclusively caused by the colonizer. At the same time, a higher risk of Gram-negative sepsis has been demonstrated in patients colonized with ESBL+ bacteria.
导言:发热性中性粒细胞减少症是干细胞移植最常见的并发症之一:发热性中性粒细胞减少症(FN)是干细胞移植最常见的并发症之一。本分析的目的是评估FN患者定植耐药革兰氏阴性菌(广谱β-内酰胺酶阳性、耐多药(MDR)铜绿假单胞菌)后发生败血症的频率,以及定植患者主要抗生素的选择:这是一项回顾性研究,分析了2018年1月1日至2022年9月9日接受造血干细胞移植患者的数据。数据来自医院信息系统:10.9%的非定植+/-AmpC患者、31.5%的ESBL+患者和0%的MDR铜绿假单胞菌患者选择碳青霉烯作为主要抗生素。FN 和 MDR 铜绿假单胞菌定植患者的败血症发病率较高(即 100%,p = 0.0197)。败血症的谱系似乎有所不同,ESBL+组中革兰氏阴性杆菌占多数(p = 0.0123,OR 5.39 [95% CI 1.55-18.76])。MDR铜绿假单胞菌定植的脓毒症患者中100%出现定植者脓毒症(p=0.002),所有患者均为异体移植(p=0.0003),死亡率为33.3%(p=0.0384)。ESBL+定植患者的败血症发生率为25.9%(p=0.0197),其中50%的败血症病例为定植败血症(p=0.0002),大部分为异体移植(p=0.0003):结果表明,铜绿假单胞菌MDR定植的FN患者发生败血症的风险很高,这种情况几乎完全由定植者引起。同时,ESBL+细菌定植的患者发生革兰氏阴性败血症的风险更高。
{"title":"The role of colonization with resistant Gram-negative bacteria in the treatment of febrile neutropenia after stem cell transplantation","authors":"T. Sokolová ,&nbsp;P. Paterová ,&nbsp;A. Zavřelová ,&nbsp;B. Víšek ,&nbsp;P. Žák ,&nbsp;J. Radocha","doi":"10.1016/j.jhin.2024.08.012","DOIUrl":"10.1016/j.jhin.2024.08.012","url":null,"abstract":"<div><h3>Background</h3><div>Febrile neutropenia (FN) is a common complication of stem cell transplantation.</div></div><div><h3>Aim</h3><div>To evaluate the frequency of sepsis in patients with FN colonized with resistant Gram-negative bacteria (extended-spectrum β-lactamase (ESBL)-positive, multidrug-resistant (MDR) <em>Pseudomonas aeruginosa</em>) and the choice of primary antibiotic in colonized patients.</div></div><div><h3>Methods</h3><div>This retrospective study analysed data from patients undergoing haematopoietic stem cell transplantation from January 2018 to September 2022. Data were extracted from the hospital information system.</div></div><div><h3>Findings</h3><div>Carbapenem as the primary antibiotic of choice was chosen in 10.9% of non-colonized +/–AmpC patients, 31.5% of ESBL<sup>+</sup> patients, and 0% of MDR <em>P. aeruginosa</em> patients. Patients with FN and MDR <em>P. aeruginosa</em> colonization had a high prevalence of sepsis (namely 100%, <em>P</em> = 0.0197). The spectrum of sepsis appeared to be different, with Gram-negative bacilli predominating in the ESBL<sup>+</sup> group (OR: 5.39; 95% CI: 1.55–18.76; <em>P</em> = 0.0123). Colonizer sepsis was present in 100% of sepsis with MDR <em>P. aeruginosa</em> colonization (<em>P</em> = 0.002), all in allogeneic transplantation (<em>P</em> = 0.0003), with a mortality rate of 33.3% (<em>P</em> = 0.0384). The incidence of sepsis in patients with ESBL<sup>+</sup> colonization was 25.9% (<em>P</em> = 0.0197), with colonizer sepsis in 50% of sepsis cases (<em>P</em> = 0.0002), most in allogeneic transplantation (<em>P</em> = 0.0003).</div></div><div><h3>Conclusion</h3><div>The results show a significant risk of sepsis in FN with MDR <em>P. aeruginosa</em> colonization, a condition almost exclusively caused by the colonizer. At the same time, a higher risk of Gram-negative sepsis has been demonstrated in patients colonized with ESBL<sup>+</sup> bacteria.</div></div>","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":"153 ","pages":"Pages 73-80"},"PeriodicalIF":3.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142301271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inverse probability weighting leads to more accurate incidence estimates for healthcare-associated infections in intensive care units - results from two national surveillance systems. 反概率加权法可更准确地估算重症监护室医护相关感染的发病率,这是两个国家监测系统得出的结果。
IF 3.9 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-30 DOI: 10.1016/j.jhin.2024.10.009
C Vicentini, R Bussolino, M Perego, D Silengo, F D'Ancona, S Finazzi, C M Zotti

Background: Two main approaches are employed to monitor healthcare-associated infections (HAIs): longitudinal surveillance, which allows the measurement of incidence rates, and point prevalence surveys (PPSs). PPSs are less time-consuming; however, they are affected by length-biased sampling, which can be corrected through inverse probability weighting. We assessed the accuracy of this method by analysing data from two Italian national surveillance systems.

Methods: Ventilator-associated pneumonia (VAP) and central-line-associated bloodstream infection (CLABSI) incidence measured through a prospective surveillance system (GiViTI) was compared with incidence estimates obtained through conversion of crude and inverse probability weighted prevalence of the same HAIs in intensive care units (ICUs) measured through a PPS. Weighted prevalence rates were obtained after weighting all patients inversely proportional to their time-at-risk. Prevalence rates were converted into incidence per 100 admissions using an adapted version of the Rhame and Sudderth formula.

Findings: Overall, 30,988 patients monitored through GiViTI, and 1435 patients monitored through the PPS were included. A significant difference was found between incidence rates estimated based on crude VAP and CLABSI prevalence and measured through GiViTI (relative risk 2.5 and 3.36; 95% confidence interval 1.42-4.39 and 1.33-8.53, P=0.006 and 0.05, respectively). Conversely, no significant difference was found between incidence rates estimated based on weighted VAP and CLABSI prevalence and measured through GiViTI (P=0.927 and 0.503, respectively).

Conclusions: When prospective surveillance is not feasible, our simple method could be useful to obtain more accurate incidence rates from PPS data.

背景:监测医疗相关感染(HAIs)主要采用两种方法:纵向监测(可测量发病率)和点流行率调查(PPS)。点流行率调查耗时较少,但受长度偏差采样的影响,可通过反概率加权法加以纠正。我们通过分析意大利两个国家监测系统的数据,评估了这种方法的准确性:通过前瞻性监控系统(GiViTI)测得的呼吸机相关肺炎(VAP)和中心管路相关血流感染(CLABSI)发病率与通过 PPS 测得的重症监护病房(ICU)中相同 HAIs 的粗略和反概率加权流行率换算得出的发病率估计值进行了比较。加权患病率是根据所有患者的风险时间按反比例加权得出的。使用改编版的 Rhame 和 Sudderth 公式将流行率转换为每 100 例住院的发病率:总共纳入了 30988 名通过 GiViTI 监测的患者和 1435 名通过 PPS 监测的患者。根据粗略 VAP 和 CLABSI 感染率估算的发病率与通过 GiViTI 测定的发病率之间存在明显差异(相对风险,RR 分别为 2.5 和 3.36;95% 置信区间,CI 分别为 1.42 - 4.39 和 1.33 - 8.53,p = 0.006 和 0.05)。相反,根据加权 VAP 和 CLABSI 感染率估算的发病率与通过 GiViTI 测量的发病率之间没有发现明显差异(p = 0.927 和 0.503):结论:在前瞻性监测不可行的情况下,我们的简单方法可用于从 PPS 数据中获得更准确的发病率。
{"title":"Inverse probability weighting leads to more accurate incidence estimates for healthcare-associated infections in intensive care units - results from two national surveillance systems.","authors":"C Vicentini, R Bussolino, M Perego, D Silengo, F D'Ancona, S Finazzi, C M Zotti","doi":"10.1016/j.jhin.2024.10.009","DOIUrl":"10.1016/j.jhin.2024.10.009","url":null,"abstract":"<p><strong>Background: </strong>Two main approaches are employed to monitor healthcare-associated infections (HAIs): longitudinal surveillance, which allows the measurement of incidence rates, and point prevalence surveys (PPSs). PPSs are less time-consuming; however, they are affected by length-biased sampling, which can be corrected through inverse probability weighting. We assessed the accuracy of this method by analysing data from two Italian national surveillance systems.</p><p><strong>Methods: </strong>Ventilator-associated pneumonia (VAP) and central-line-associated bloodstream infection (CLABSI) incidence measured through a prospective surveillance system (GiViTI) was compared with incidence estimates obtained through conversion of crude and inverse probability weighted prevalence of the same HAIs in intensive care units (ICUs) measured through a PPS. Weighted prevalence rates were obtained after weighting all patients inversely proportional to their time-at-risk. Prevalence rates were converted into incidence per 100 admissions using an adapted version of the Rhame and Sudderth formula.</p><p><strong>Findings: </strong>Overall, 30,988 patients monitored through GiViTI, and 1435 patients monitored through the PPS were included. A significant difference was found between incidence rates estimated based on crude VAP and CLABSI prevalence and measured through GiViTI (relative risk 2.5 and 3.36; 95% confidence interval 1.42-4.39 and 1.33-8.53, P=0.006 and 0.05, respectively). Conversely, no significant difference was found between incidence rates estimated based on weighted VAP and CLABSI prevalence and measured through GiViTI (P=0.927 and 0.503, respectively).</p><p><strong>Conclusions: </strong>When prospective surveillance is not feasible, our simple method could be useful to obtain more accurate incidence rates from PPS data.</p>","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":" ","pages":"73-81"},"PeriodicalIF":3.9,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical site infection prevention care bundles in colorectal surgery: a scoping review. 结直肠手术中的手术部位感染预防护理捆绑:范围界定综述。
IF 3.9 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-30 DOI: 10.1016/j.jhin.2024.10.010
Tiago Cunha, Susana Miguel, João Maciel, Carlos Zagalo, Paulo Alves

Background: Surgical site infection preventions bundles have been used to reduce infection rate in most types of surgery. In colorectal surgery they have been used with success as well, with tailored care bundles designed for that purpose.

Aim: To identify and review the individual interventions that constitute each infection prevention care bundle in colorectal surgery, and the surgical site infection rate reduction related to their implementation.

Methods: A scoping review was conducted in PUBMED, CINAHL; Web of Science Core Collection and Scopus databases, during December 2022.

Results: This review analysed 48 of 164 identified studies on surgical site infection (SSI) prevention in colorectal surgery from 2011 to 2022. It revealed an average of 11 interventions per study, primarily in preoperative (mechanical bowel preparation, oral antibiotic bowel decontamination, hair removal, CHG showers, normoglycemia), intraoperative (antibiotic prophylaxis, normothermia, CHG skin preparation, antibiotic prophylaxis re-dosing, gown/glove change), and postoperative phases (normothermia, normoglycemia, dressing removal, oxygen optimization, incision cleansing). Despite these interventions, SSI rates remain high, indicating a need for further research to optimize intervention bundles and improve compliance across surgical stages.

Conclusions: The implementation of Surgical Site Infection prevention bundles, tailored to Colorectal surgery, have shown a reduction in surgical site infection rates and costs. Grouping intervention according to the perioperative phase, may contribute to increased compliance rates.

背景:手术部位感染预防包已被用于降低大多数类型手术的感染率。目的:确定并回顾构成结直肠手术感染预防护理包的各项干预措施,以及与实施这些措施相关的手术部位感染率降低情况:方法:2022 年 12 月,在 PUBMED、CINAHL、Web of Science Core Collection 和 Scopus 数据库中进行了范围界定综述:本综述分析了 2011 年至 2022 年间 164 项已确定的结直肠手术中手术部位感染 (SSI) 预防研究中的 48 项。结果显示,每项研究平均采取了 11 项干预措施,主要涉及术前(机械肠道准备、口服抗生素肠道净化、脱毛、CHG 淋浴、正常血糖)、术中(抗生素预防、正常体温、CHG 皮肤准备、抗生素预防再用药、更换手术衣/手套)和术后阶段(正常体温、正常血糖、去除敷料、氧气优化、切口清洁)。尽管采取了这些干预措施,但 SSI 感染率仍然很高,这表明有必要进一步开展研究,优化干预措施捆绑,提高各手术阶段的依从性:结论:针对结直肠手术实施的手术部位感染预防捆绑措施已显示出手术部位感染率和成本的降低。根据围手术期进行分组干预可能有助于提高依从率。
{"title":"Surgical site infection prevention care bundles in colorectal surgery: a scoping review.","authors":"Tiago Cunha, Susana Miguel, João Maciel, Carlos Zagalo, Paulo Alves","doi":"10.1016/j.jhin.2024.10.010","DOIUrl":"https://doi.org/10.1016/j.jhin.2024.10.010","url":null,"abstract":"<p><strong>Background: </strong>Surgical site infection preventions bundles have been used to reduce infection rate in most types of surgery. In colorectal surgery they have been used with success as well, with tailored care bundles designed for that purpose.</p><p><strong>Aim: </strong>To identify and review the individual interventions that constitute each infection prevention care bundle in colorectal surgery, and the surgical site infection rate reduction related to their implementation.</p><p><strong>Methods: </strong>A scoping review was conducted in PUBMED, CINAHL; Web of Science Core Collection and Scopus databases, during December 2022.</p><p><strong>Results: </strong>This review analysed 48 of 164 identified studies on surgical site infection (SSI) prevention in colorectal surgery from 2011 to 2022. It revealed an average of 11 interventions per study, primarily in preoperative (mechanical bowel preparation, oral antibiotic bowel decontamination, hair removal, CHG showers, normoglycemia), intraoperative (antibiotic prophylaxis, normothermia, CHG skin preparation, antibiotic prophylaxis re-dosing, gown/glove change), and postoperative phases (normothermia, normoglycemia, dressing removal, oxygen optimization, incision cleansing). Despite these interventions, SSI rates remain high, indicating a need for further research to optimize intervention bundles and improve compliance across surgical stages.</p><p><strong>Conclusions: </strong>The implementation of Surgical Site Infection prevention bundles, tailored to Colorectal surgery, have shown a reduction in surgical site infection rates and costs. Grouping intervention according to the perioperative phase, may contribute to increased compliance rates.</p>","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of vancomycin-resistant Enterococcus faecium in Dutch healthcare institutes: a nationwide survey. 荷兰医疗机构对耐万古霉素肠球菌的管理:一项全国性调查。
IF 3.9 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-29 DOI: 10.1016/j.jhin.2024.09.028
M Mulder, K E W Vendrik, S A M van Kessel, D W Notermans, A F Schoffelen, J Flipse, A P A Hendrickx, W C van der Zwet, C Schneeberger-van der Linden

Background: Vancomycin-resistant Enterococcus faecium (VREfm) is an opportunistic pathogen, which can cause outbreaks in hospitals. In the Netherlands, several national guidelines and guidance documents on different aspects of VREfm management are available. Most available guidelines are written towards the hospital setting and only few on long-term care facilities (LTCFs). Moreover, not all aspects of VREfm management are covered, recommendations differ and the level of compliance to these guidelines is unknown. The aim of this study was to get insight into the routine VREfm policies in Dutch healthcare facilities with regard to screening, diagnostics and infection control measures.

Methods: Online questionnaires were sent to representatives of Dutch hospitals and LTCFs. The questionnaire included questions regarding the definition of VRE, screening, diagnostics, patient isolation, cleaning procedures, VREfm clearance and VREfm outbreaks.

Findings: The questionnaire was completed by 61 hospitals with a response rate of 84.1% and 57 LTCFs, mostly nursing homes. Most hospitals reported VREfm outbreaks in the previous decade, whereas only one LTCF reported an outbreak. Of the hospitals, 87% perform VREfm screening versus 50% of the LTCFs. VREfm-positive patients are isolated in 98% of hospitals and 83% of LTCFs. Protocols regarding how to unlabel VREfm-positive patients are in place in 84% of the hospitals and in 51% of LTCFs. The details of these measures differ substantially between healthcare facilities.

Conclusion: This study has shown that most hospitals and some LTCFs in the Netherlands have standard procedures for VREfm management to some level, although the comprehensiveness and details of the measures differ per hospital. More uniform policies would improve comparability of VREfm data on a regional/national level.

背景:耐万古霉素粪肠球菌(VREfm)是一种机会性病原体,可在医院引起疾病暴发。荷兰针对 VREfm 管理的不同方面制定了多份国家指南和指导文件。大多数指南都是针对医院环境编写的,只有少数指南涉及长期护理机构(LTCF)。此外,这些指南并没有涵盖 VREfm 管理的所有方面,提出的建议也不尽相同,对这些指南的遵守程度也不得而知。本研究旨在了解荷兰医疗机构在筛查、诊断和感染控制措施方面的常规 VREfm 政策:向荷兰医院和长期护理机构(LTCF)的代表发送了在线调查问卷。调查问卷包括有关 VRE 的定义、筛查、诊断、患者隔离、清洁程序、VREfm 清除率和 VREfm 爆发的问题:61 家医院(回复率为 84.1%)和 57 家 LTCF(主要是疗养院)填写了调查问卷。大多数医院报告在过去十年中爆发过弧菌感染,而只有一家 LTCF 报告爆发过弧菌感染。在医院中,87% 的医院进行了 VREfm 筛查,而 50% 的 LTCFs 进行了 VREfm 筛查。98% 的医院和 83% 的 LTCF 隔离了 VRE 阳性患者。84% 的医院和 51% 的 LTCF 制定了关于如何取消对 VRE 阳性患者标记的协议。这些措施的细节在不同的医疗机构之间存在很大差异:这项研究表明,荷兰大多数医院和一些 LTCF 在某种程度上都有管理 VREfm 的标准程序,但每家医院的措施的全面性和细节各不相同。更加统一的政策将提高地区/国家层面上 VREfm 数据的可比性。
{"title":"Management of vancomycin-resistant Enterococcus faecium in Dutch healthcare institutes: a nationwide survey.","authors":"M Mulder, K E W Vendrik, S A M van Kessel, D W Notermans, A F Schoffelen, J Flipse, A P A Hendrickx, W C van der Zwet, C Schneeberger-van der Linden","doi":"10.1016/j.jhin.2024.09.028","DOIUrl":"10.1016/j.jhin.2024.09.028","url":null,"abstract":"<p><strong>Background: </strong>Vancomycin-resistant Enterococcus faecium (VRE<sub>fm</sub>) is an opportunistic pathogen, which can cause outbreaks in hospitals. In the Netherlands, several national guidelines and guidance documents on different aspects of VRE<sub>fm</sub> management are available. Most available guidelines are written towards the hospital setting and only few on long-term care facilities (LTCFs). Moreover, not all aspects of VRE<sub>fm</sub> management are covered, recommendations differ and the level of compliance to these guidelines is unknown. The aim of this study was to get insight into the routine VRE<sub>fm</sub> policies in Dutch healthcare facilities with regard to screening, diagnostics and infection control measures.</p><p><strong>Methods: </strong>Online questionnaires were sent to representatives of Dutch hospitals and LTCFs. The questionnaire included questions regarding the definition of VRE, screening, diagnostics, patient isolation, cleaning procedures, VRE<sub>fm</sub> clearance and VRE<sub>fm</sub> outbreaks.</p><p><strong>Findings: </strong>The questionnaire was completed by 61 hospitals with a response rate of 84.1% and 57 LTCFs, mostly nursing homes. Most hospitals reported VRE<sub>fm</sub> outbreaks in the previous decade, whereas only one LTCF reported an outbreak. Of the hospitals, 87% perform VRE<sub>fm</sub> screening versus 50% of the LTCFs. VRE<sub>fm</sub>-positive patients are isolated in 98% of hospitals and 83% of LTCFs. Protocols regarding how to unlabel VRE<sub>fm</sub>-positive patients are in place in 84% of the hospitals and in 51% of LTCFs. The details of these measures differ substantially between healthcare facilities.</p><p><strong>Conclusion: </strong>This study has shown that most hospitals and some LTCFs in the Netherlands have standard procedures for VRE<sub>fm</sub> management to some level, although the comprehensiveness and details of the measures differ per hospital. More uniform policies would improve comparability of VRE<sub>fm</sub> data on a regional/national level.</p>","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":" ","pages":"51-59"},"PeriodicalIF":3.9,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccination of healthcare workers against mpox: a call for action. 医护人员接种麻风腮疫苗:行动呼吁。
IF 3.9 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-25 DOI: 10.1016/j.jhin.2024.10.007
Giuseppe Lippi, Brandon M Henry, John G Rizk
{"title":"Vaccination of healthcare workers against mpox: a call for action.","authors":"Giuseppe Lippi, Brandon M Henry, John G Rizk","doi":"10.1016/j.jhin.2024.10.007","DOIUrl":"https://doi.org/10.1016/j.jhin.2024.10.007","url":null,"abstract":"","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subcutaneous tunneling versus conventional insertion of peripherally inserted central catheters in hospitalized patients (TUNNEL-PICC): a multicentre, open-label, randomized, controlled trial. 住院病人皮下隧道植入外周置入中心导管与传统植入外周置入中心导管的比较(TUNNEL-PICC):一项多中心、开放标签、随机对照试验。
IF 3.9 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-25 DOI: 10.1016/j.jhin.2024.10.008
Eung Tae Kim, Jae Hwan Lee, Dong Jae Shim, Yohan Kwon, Soo Buem Cho, Ki Jun Kim, Doyoung Kim, Jinoo Kim, Eu Suk Kim, Hoyong Jun, Youn Jeong Kim, Jinyeong Kim, Eun Jin Kim, Chung-Jong Kim, Kang-Il Jun, Myoung Jin Shin, Chang Jin Yoon, Seungjae Lee, Soon-Young Song, Je Hwan Won

Objective: We aimed to evaluate whether subcutaneous tunneling in peripherally inserted central catheters (PICC) placement could reduce the occurrence of central-line associated blood stream infection (CLABSI).

Methods: We conducted an open-label, multicentre, randomized, controlled trial in five tertiary hospitals. Adult hospitalized patients requiring a PICC were randomized in a one-to-one ratio to conventional (cPICC) or tunneled PICC (tPICC) arms using a centralized web-based computer-generated stratified randomization. CLABSI rates between groups were compared in a modified intention-to-treat population. Safety including the incidence of exit-site infection or hemorrhage-associated catheter removal were also compared. This trial was registered with Clinical Research Information Service of Republic of Korea (KCT0005521).

Results: From November 2020 to March 2023, 1,324 participants were enrolled and randomly assigned to tPICC (n=662) and cPICC (n=662). This study was terminated early due to the cohort CLABSI rate being lower than estimated, therefore, the original sample size of 1,694 would render the study underpowered to detect a difference in CLABSI rates. In the tPICC, CLABSI occurred in 13 of 651 participants over 11,071 catheter-days (1.2/1,000 catheter-days), compared with 20 among 650 patients with cPICC over 11,141 catheter-days (1.8/1,000 catheter-days, rate ratio 0.65, 95% CI 0.30-1.38, p=0.30). The incidence of exit-site infection (29 tPICC, 36 cPICC, p=0.5) and hemorrhage-associated catheter removal (11 tPICC, 11 cPICC, p=0.99) was not different between both groups.

Conclusion: Due to insufficient sample size, this study could not demonstrate a statistically significant CLABSI risk reduction in the tPICC group compared to the cPICC group. Both groups had similar rates of exit site infection and bleeding.

目的我们旨在评估在外周置入中心导管(PICC)置管过程中采用皮下隧道疗法能否减少中心管路相关血流感染(CLABSI)的发生:我们在五家三级医院开展了一项开放标签、多中心、随机对照试验。需要使用 PICC 的成人住院患者通过基于网络的集中计算机分层随机化,以一对一的比例被随机分配到传统 PICC(cPICC)或隧道式 PICC(tPICC)组。在改良的意向治疗人群中比较了各组之间的 CLABSI 发生率。同时还比较了安全性,包括出口感染或出血相关导管拔除的发生率。该试验已在大韩民国临床研究信息服务机构注册(KCT0005521):结果:2020年11月至2023年3月,1324名参与者被随机分配到tPICC(662人)和cPICC(662人)。由于队列 CLABSI 感染率低于估计值,这项研究提前结束,因此,原样本量 1,694 人将导致该研究检测 CLABSI 感染率差异的能力不足。在 tPICC 中,651 名参与者中有 13 人在 11,071 个导管日中发生了 CLABSI(1.2/1,000 个导管日),而在 650 名 cPICC 患者中有 20 人在 11,141 个导管日中发生了 CLABSI(1.8/1,000 个导管日,比率比 0.65,95% CI 0.30-1.38,p=0.30)。两组导管出口感染(29 tPICC,36 cPICC,P=0.5)和出血相关导管拔除(11 tPICC,11 cPICC,P=0.99)的发生率没有差异:结论:由于样本量不足,本研究无法证明与 cPICC 组相比,tPICC 组的 CLABSI 风险在统计学上有显著降低。两组的出口部位感染率和出血率相似。
{"title":"Subcutaneous tunneling versus conventional insertion of peripherally inserted central catheters in hospitalized patients (TUNNEL-PICC): a multicentre, open-label, randomized, controlled trial.","authors":"Eung Tae Kim, Jae Hwan Lee, Dong Jae Shim, Yohan Kwon, Soo Buem Cho, Ki Jun Kim, Doyoung Kim, Jinoo Kim, Eu Suk Kim, Hoyong Jun, Youn Jeong Kim, Jinyeong Kim, Eun Jin Kim, Chung-Jong Kim, Kang-Il Jun, Myoung Jin Shin, Chang Jin Yoon, Seungjae Lee, Soon-Young Song, Je Hwan Won","doi":"10.1016/j.jhin.2024.10.008","DOIUrl":"https://doi.org/10.1016/j.jhin.2024.10.008","url":null,"abstract":"<p><strong>Objective: </strong>We aimed to evaluate whether subcutaneous tunneling in peripherally inserted central catheters (PICC) placement could reduce the occurrence of central-line associated blood stream infection (CLABSI).</p><p><strong>Methods: </strong>We conducted an open-label, multicentre, randomized, controlled trial in five tertiary hospitals. Adult hospitalized patients requiring a PICC were randomized in a one-to-one ratio to conventional (cPICC) or tunneled PICC (tPICC) arms using a centralized web-based computer-generated stratified randomization. CLABSI rates between groups were compared in a modified intention-to-treat population. Safety including the incidence of exit-site infection or hemorrhage-associated catheter removal were also compared. This trial was registered with Clinical Research Information Service of Republic of Korea (KCT0005521).</p><p><strong>Results: </strong>From November 2020 to March 2023, 1,324 participants were enrolled and randomly assigned to tPICC (n=662) and cPICC (n=662). This study was terminated early due to the cohort CLABSI rate being lower than estimated, therefore, the original sample size of 1,694 would render the study underpowered to detect a difference in CLABSI rates. In the tPICC, CLABSI occurred in 13 of 651 participants over 11,071 catheter-days (1.2/1,000 catheter-days), compared with 20 among 650 patients with cPICC over 11,141 catheter-days (1.8/1,000 catheter-days, rate ratio 0.65, 95% CI 0.30-1.38, p=0.30). The incidence of exit-site infection (29 tPICC, 36 cPICC, p=0.5) and hemorrhage-associated catheter removal (11 tPICC, 11 cPICC, p=0.99) was not different between both groups.</p><p><strong>Conclusion: </strong>Due to insufficient sample size, this study could not demonstrate a statistically significant CLABSI risk reduction in the tPICC group compared to the cPICC group. Both groups had similar rates of exit site infection and bleeding.</p>","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Borderline oxacillin-resistant Staphylococcus aureus: an emerging threat in the hospital environment. 边缘耐草青霉素金黄色葡萄球菌:医院环境中新出现的威胁。
IF 3.9 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-25 DOI: 10.1016/j.jhin.2024.09.029
Gareth Hughes, Susan Wilkinson, Jean Harker, Itisha Gupta, Elisabeth Holden, Mark Garvey
{"title":"Borderline oxacillin-resistant Staphylococcus aureus: an emerging threat in the hospital environment.","authors":"Gareth Hughes, Susan Wilkinson, Jean Harker, Itisha Gupta, Elisabeth Holden, Mark Garvey","doi":"10.1016/j.jhin.2024.09.029","DOIUrl":"https://doi.org/10.1016/j.jhin.2024.09.029","url":null,"abstract":"","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the clinic to the wards, the evolution of penicillin allergy testing by non-allergists in a UK hospital. 从诊所到病房,英国一家医院由非过敏学家进行青霉素过敏测试的演变。
IF 3.9 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-24 DOI: 10.1016/j.jhin.2024.09.026
Cassandra Watson, Shiv Shah, Fatema Hassan, Tina Suri, Deepa Joseph, Guduru Gopal Rao, Alastair McGregor
{"title":"From the clinic to the wards, the evolution of penicillin allergy testing by non-allergists in a UK hospital.","authors":"Cassandra Watson, Shiv Shah, Fatema Hassan, Tina Suri, Deepa Joseph, Guduru Gopal Rao, Alastair McGregor","doi":"10.1016/j.jhin.2024.09.026","DOIUrl":"https://doi.org/10.1016/j.jhin.2024.09.026","url":null,"abstract":"","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers and facilitators for using administrative data for surveillance purpose: a narrative overview. 将行政数据用于监测目的的障碍和促进因素:叙述性概述。
IF 3.9 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-23 DOI: 10.1016/j.jhin.2024.09.027
V Boulanger, A MacLaurin, C Quach

Although administrative data are not originally intended for surveillance purposes, they are frequently used for monitoring public health and patient safety. This article provides a narrative overview of the barriers and facilitators for the use of administrative data for surveillance, with a focus on healthcare-associated infection (HAI) in Canada. In this case, only articles on administrative data in general or related to HAI were included. Validation study and meta-analyses on administrative data accuracy were excluded. Medline, Embase and Google Scholar were searched as well as references list of all included articles, for a total of 90 articles included. Our analysis identified 78 barriers at the individual, organizational and systemic levels and outlined 75 facilitators and solutions to improve administrative data utilization and quality. This narrative overview will help to understand barriers, facilitators and offer practical recommendations for optimizing the use of administrative data.

尽管行政数据最初并非用于监测目的,但它们经常被用于监测公共卫生和患者安全。本文概述了使用行政数据进行监测的障碍和促进因素,重点关注加拿大的医疗相关感染 (HAI)。在这种情况下,只纳入了一般行政数据或与 HAI 相关的文章。有关行政数据准确性的验证研究和荟萃分析不包括在内。我们检索了 Medline、Embase 和 Google Scholar 以及所有收录文章的参考文献列表,共收录了 90 篇文章。我们的分析确定了个人、组织和系统层面的 78 个障碍,并概述了 75 个促进因素和解决方案,以提高行政数据的利用率和质量。这一叙述性概述将有助于了解障碍和促进因素,并为优化行政数据的使用提供实用建议。
{"title":"Barriers and facilitators for using administrative data for surveillance purpose: a narrative overview.","authors":"V Boulanger, A MacLaurin, C Quach","doi":"10.1016/j.jhin.2024.09.027","DOIUrl":"10.1016/j.jhin.2024.09.027","url":null,"abstract":"<p><p>Although administrative data are not originally intended for surveillance purposes, they are frequently used for monitoring public health and patient safety. This article provides a narrative overview of the barriers and facilitators for the use of administrative data for surveillance, with a focus on healthcare-associated infection (HAI) in Canada. In this case, only articles on administrative data in general or related to HAI were included. Validation study and meta-analyses on administrative data accuracy were excluded. Medline, Embase and Google Scholar were searched as well as references list of all included articles, for a total of 90 articles included. Our analysis identified 78 barriers at the individual, organizational and systemic levels and outlined 75 facilitators and solutions to improve administrative data utilization and quality. This narrative overview will help to understand barriers, facilitators and offer practical recommendations for optimizing the use of administrative data.</p>","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":" ","pages":"25-36"},"PeriodicalIF":3.9,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergence of Mycobacterium gordonae in heater–cooler units: a five-year prospective surveillance of devices frequently subjected to chloramine-T booster disinfection 加热器冷却器中出现戈登分枝杆菌:对经常使用氯胺-T 强化消毒的设备进行为期五年的前瞻性监测。
IF 3.9 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-22 DOI: 10.1016/j.jhin.2024.10.006
S. Ditommaso , J. Garlasco , G. Memoli , A. Curtoni , A. Bondi , A. Ceccarelli , M. Giacomuzzi

Background

Worldwide, the detection of Mycobacterium chimaera in LivaNova heater–cooler units (HCUs) has led to their replacement with other HCUs, although non-tuberculous mycobacteria (NTM) have been reported also for HCUs produced by other manufacturers. In almost all hospitals of our region, LivaNova HCUs have been replaced with Maquet HCU40s, regularly disinfected with chloramine-T.

Aim

To report the results of the surveillance over a 63-month operation period of the Maquet devices, and to provide a trend in NTM positivity over time.

Methods

Twenty-nine Maquet devices (HCU40 and HU35) were monitored by two culture methods and propidium monoazide polymerase chain reaction (PMA-PCR) method. The trend in NTM positivity rate was evaluated through the Locally Estimated Scatterplot Smoothing regression and then modelled over time through segmented logistic regression.

Findings

The data acquired during the study period demonstrate a remarkable increase in the positivity rate, especially after the third year (maximum slope change at 1280 days). Non-tuberculous mycobacteria were isolated in 150 water samples (37.2%); 100% and 62% of HCU40 and HU35 devices, respectively, were colonized with non-tuberculous mycobacteria. The most frequently detected species were Mycobacterium gordonae (73%) followed by Mycobacterium chelonae (41%) and Mycobacterium paragordonae (11%).

Conclusion

Preventive strategies by disinfection with chloramine-T did not effectively reduce non-tuberculous mycobacteria colonization of Maquet devices. Although, to date, no cases of postoperative invasive infections linked to Maquet devices have been reported, our microbiological results emphasize the need for (1) designing changes to increase safety of devices and (2) researching and developing new disinfection protocols including alternative molecules.
背景:在全球范围内,由于在 LivaNova 加热器-冷却器(HCU)中发现了分枝杆菌,因此已用其他 HCU 取而代之,尽管其他制造商生产的 HCU 中也有非结核分枝杆菌(NTM)的报道。在我们地区的几乎所有医院中,LivaNova HCU 已被 Maquet HCU40 取代,并定期用氯胺酮 T 消毒:采用两种培养方法和 PMA-PCR 方法对 29 台 Maquet 设备(HCU40 和 HU35)进行了监测。通过局部估计散点图平滑回归评估了 NTM 阳性率的趋势,然后通过分段逻辑回归建立了随时间变化的模型:研究期间获得的数据表明,阳性率显著上升,尤其是在第三年之后(1280 天时斜率变化最大)。在 150 份水样(37.2%)中分离出了非结核分枝杆菌;HCU40 和 HU35 设备中分别有 100% 和 62% 滋生了非结核分枝杆菌。最常检测到的菌种是戈登分枝杆菌(73%),其次是螯合分枝杆菌(41%)和副戈登分枝杆菌(11%):结论:使用氯胺-T 消毒的预防策略并不能有效减少 Maquet 设备中的非结核分枝杆菌定植。尽管迄今为止还没有与 Maquet 设备相关的术后侵入性感染病例的报道,但我们的微生物学研究结果强调了以下两方面的必要性:1)改变设计以提高设备的安全性;2)研究和开发包括替代分子在内的新消毒方案。
{"title":"Emergence of Mycobacterium gordonae in heater–cooler units: a five-year prospective surveillance of devices frequently subjected to chloramine-T booster disinfection","authors":"S. Ditommaso ,&nbsp;J. Garlasco ,&nbsp;G. Memoli ,&nbsp;A. Curtoni ,&nbsp;A. Bondi ,&nbsp;A. Ceccarelli ,&nbsp;M. Giacomuzzi","doi":"10.1016/j.jhin.2024.10.006","DOIUrl":"10.1016/j.jhin.2024.10.006","url":null,"abstract":"<div><h3>Background</h3><div>Worldwide, the detection of <em>Mycobacterium chimaera</em> in LivaNova heater–cooler units (HCUs) has led to their replacement with other HCUs, although non-tuberculous mycobacteria (NTM) have been reported also for HCUs produced by other manufacturers. In almost all hospitals of our region, LivaNova HCUs have been replaced with Maquet HCU40s, regularly disinfected with chloramine-T.</div></div><div><h3>Aim</h3><div>To report the results of the surveillance over a 63-month operation period of the Maquet devices, and to provide a trend in NTM positivity over time.</div></div><div><h3>Methods</h3><div>Twenty-nine Maquet devices (HCU40 and HU35) were monitored by two culture methods and propidium monoazide polymerase chain reaction (PMA-PCR) method. The trend in NTM positivity rate was evaluated through the Locally Estimated Scatterplot Smoothing regression and then modelled over time through segmented logistic regression.</div></div><div><h3>Findings</h3><div>The data acquired during the study period demonstrate a remarkable increase in the positivity rate, especially after the third year (maximum slope change at 1280 days). Non-tuberculous mycobacteria were isolated in 150 water samples (37.2%); 100% and 62% of HCU40 and HU35 devices, respectively, were colonized with non-tuberculous mycobacteria. The most frequently detected species were <em>Mycobacterium gordonae</em> (73%) followed by <em>Mycobacterium chelonae</em> (41%) and <em>Mycobacterium paragordonae</em> (11%).</div></div><div><h3>Conclusion</h3><div>Preventive strategies by disinfection with chloramine-T did not effectively reduce non-tuberculous mycobacteria colonization of Maquet devices. Although, to date, no cases of postoperative invasive infections linked to Maquet devices have been reported, our microbiological results emphasize the need for (1) designing changes to increase safety of devices and (2) researching and developing new disinfection protocols including alternative molecules.</div></div>","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":"155 ","pages":"Pages 9-16"},"PeriodicalIF":3.9,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Hospital Infection
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1